Luis Rubio • UCSF Profiles

Luis Rubio, MD, MHS

Title(s)	Assistant Professor, Medicine
School	School of Medicine
Pronouns	He/Him/His
vCard	Download vCard

Biography

education and training

University of California San Francisco	Fellowship	06/2021	Infectious Diseases
University of California San Francisco	Residency	06/2019	Internal Medicine
Yale University School of Medicine	MD, MHS	05/2016
University of Texas El Paso	BS	05/2011	Biology

Overview

overview

Dr. Luis Alberto Rubio is an infectious disease specialist who provides primary care for patients living with HIV or AIDS. His professional interests include HIV prevention and treating latent (asymptomatic) tuberculosis infections.

In research, Rubio is interested in medical education and health care access for marginalized populations, especially those disproportionately impacted by such infections as HIV, COVID-19 and tuberculosis.

Rubio earned his medical degree and master of health science degree from the Yale School of Medicine. At UCSF, he completed a residency in internal medicine and a fellowship in infectious diseases.

media links

	Se reporta una nueva cepa de mpox en el condado de San Mateo (11/16/2024)
	Latinx Low-Income Workers Hardest Hit by SF COVID-19 Surge (12/10/2020)
	SF woman who will have fingers amputated after nearly dying from COVID-19, still hesitant about vaccine (12/18/2020)
	Celebran la aprobación para el uso de la vacuna de Johnson&Jonhson (04/23/2021)
	Current Numbers Don't Reflect Reality of COVID Surge: Health Experts (7/15/2022)
	Preocupante aumento de casos de COVID-19 en San Francisco (06/03/2022)
	Viruela del mono: Contagios siguen aumentando en San Francisco, mientras miles de personas esperan ser vacunadas (8/2/2022)
	A man in California has tested positive for a new tick-borne disease. Here's what to know about hard tick relapsing fever, and where it is in the US. (4/14/2023)

Bibliographic

selected publications

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.

Altmetrics Details

PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.

Vaccine breakthrough hypoxemic COVID-19 pneumonia in patients with auto-Abs neutralizing type I IFNs. Sci Immunol. 2023 12 22; 8(90):eabp8966. Bastard P, Vazquez SE, Liu J, Laurie MT, Wang CY, Gervais A, Le Voyer T, Bizien L, Zamecnik C, Philippot Q, Rosain J, Catherinot E, Willmore A, Mitchell AM, Bair R, Garçon P, Kenney H, Fekkar A, Salagianni M, Poulakou G, Siouti E, Sahanic S, Tancevski I, Weiss G, Nagl L, Manry J, Duvlis S, Arroyo-Sánchez D, Paz Artal E, Rubio L, Perani C, Bezzi M, Sottini A, Quaresima V, Roussel L, Vinh DC, Reyes LF, Garzaro M, Hatipoglu N, Boutboul D, Tandjaoui-Lambiotte Y, Borghesi A, Aliberti A, Cassaniti I, Venet F, Monneret G, Halwani R, Sharif-Askari NS, Danielson J, Burrel S, Morbieu C, Stepanovskyy Y, Bondarenko A, Volokha A, Boyarchuk O, Gagro A, Neuville M, Neven B, Keles S, Hernu R, Bal A, Novelli A, Novelli G, Saker K, Ailioaie O, Antolí A, Jeziorski E, Rocamora-Blanch G, Teixeira C, Delaunay C, Lhuillier M, Le Turnier P, Zhang Y, Mahevas M, Pan-Hammarström Q, Abolhassani H, Bompoil T, Dorgham K, COVID HGE Consortium, French COVID Study Group, COMET Consortium, Gorochov G, Laouenan C, Rodríguez-Gallego C, Ng LFP, Renia L, Pujol A, Belot A, Raffi F, Allende LM, Martinez-Picado J, Ozcelik T, Imberti L, Notarangelo LD, Troya J, Solanich X, Zhang SY, Puel A, Wilson MR, Trouillet-Assant S, Abel L, Jouanguy E, Ye CJ, Cobat A, Thompson LM, Andreakos E, Zhang Q, Anderson MS, Casanova JL, DeRisi JL. PMID: 35857576; PMCID: PMC9210448.

View in: PubMed Mentions: 39 Fields:
All Allergy and Immunology
Translation:Humans Cells PHPublic Health
Borrelia miyamotoi Infection in Immunocompromised Man, California, USA, 2021. Emerging Infectious Diseases. 2023; 29(5):1101-1104. Rubio, L. A., Kjemtrup, A. M., Marx, G. E., Cronan, S., Kilonzo, C., Saunders, M. E. M., Choat, J. L., Dietrich, E. A., Liebman, K. A., & Park, S. Y. View Publication.
SARS-CoV-2 Variant Exposures Elicit Antibody Responses With Differential Cross-Neutralization of Established and Emerging Strains Including Delta and Omicron. J Infect Dis. 2022 06 01; 225(11):1909-1914. Laurie MT, Liu J, Sunshine S, Peng J, Black D, Mitchell AM, Mann SA, Pilarowski G, Zorn KC, Rubio L, Bravo S, Marquez C, Sabatino JJ, Mittl K, Petersen M, Havlir D, DeRisi J. PMID: 34979030; PMCID: PMC8755395.

View in: PubMed Mentions: 38 Fields:
Com Communicable Diseases
Translation:Humans Cells
Field Performance and Public Health Response Using the BinaxNOWTM Rapid Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antigen Detection Assay During Community-Based Testing. Clin Infect Dis. 2021 11 02; 73(9):e3098-e3101. Pilarowski G, Marquez C, Rubio L, Peng J, Martinez J, Black D, Chamie G, Jones D, Jacobo J, Tulier-Laiwa V, Rojas S, Rojas S, Cox C, Nakamura R, Petersen M, DeRisi J, Havlir DV. PMID: 33367619; PMCID: PMC7799223.

View in: PubMed Mentions: 60 Fields:
Com Communicable Diseases
Translation:Humans Cells PHPublic Health
A multi-component, community-based strategy to facilitate COVID-19 vaccine uptake among Latinx populations: From theory to practice. PLoS One. 2021; 16(9):e0257111. Marquez C, Kerkhoff AD, Naso J, Contreras MG, Castellanos Diaz E, Rojas S, Peng J, Rubio L, Jones D, Jacobo J, Rojas S, Gonzalez R, Fuchs JD, Black D, Ribeiro S, Nossokoff J, Tulier-Laiwa V, Martinez J, Chamie G, Pilarowski G, DeRisi J, Petersen M, Havlir DV. PMID: 34543291; PMCID: PMC8452046.

View in: PubMed Mentions: 54 Fields:
Med Medicine (General)Sci Science
Translation:Humans PHPublic Health
High likelihood of accepting COVID-19 vaccine in a Latinx community at high SARS-CoV2 risk in San Francisco. Open Forum Infectious Diseases. 2021. Peng J, Marquez C, Rubio L, Chamie G, Jones D, Jacobo J, Rojas S, Rojas S, Tulier-Laiwa V, Black D, Martinez J, Pilarowski G, Cox C, Derisi J, Havlir H, Petersen M. View Publication.
Performance Characteristics of a Rapid Severe Acute Respiratory Syndrome Coronavirus 2 Antigen Detection Assay at a Public Plaza Testing Site in San Francisco. J Infect Dis. 2021 04 08; 223(7):1139-1144. Pilarowski G, Lebel P, Sunshine S, Liu J, Crawford E, Marquez C, Rubio L, Chamie G, Martinez J, Peng J, Black D, Wu W, Pak J, Laurie MT, Jones D, Miller S, Jacobo J, Rojas S, Rojas S, Nakamura R, Tulier-Laiwa V, Petersen M, Havlir DV, DeRisi J. PMID: 33394052; PMCID: PMC7799021.

View in: PubMed Mentions: 101 Fields:
Com Communicable Diseases
Translation:Humans Cells
Estimation of secondary household attack rates for emergent SARS-CoV-2 variants detected by genomic surveillance at a community-based testing site in San Francisco. medRxiv. 2021 Mar 03. Peng J, Mann SA, Mitchell AM, Liu J, Laurie MT, Sunshine S, Pilarowski G, Ayscue P, Kistler A, Vanaerschot M, Li LM, McGeever A, Chow ED, Team I, Marquez C, Nakamura R, Rubio L, Chamie G, Jones D, Jacobo J, Rojas S, Rojas S, Tulier-Laiwa V, Black D, Martinez J, Naso J, Schwab J, Petersen M, Havlir D, DeRisi J. PMID: 33688689; PMCID: PMC7941666.

View in: PubMed Mentions:
Experiences of Latinx Individuals Hospitalized for COVID-19: A Qualitative Study. JAMA Netw Open. 2021 03 01; 4(3):e210684. Cervantes L, Martin M, Frank MG, Farfan JF, Kearns M, Rubio LA, Tong A, Matus Gonzalez A, Camacho C, Collings A, Mundo W, Powe NR, Fernandez A. PMID: 33704475; PMCID: PMC7953277.

View in: PubMed Mentions: 60 Fields:
Med Medicine (General)
Translation:Humans Cells PHPublic Health
The COVID-19 Symptom to Isolation Cascade in a Latinx Community: A Call to Action. Open Forum Infect Dis. 2021 Feb; 8(2):ofab023. Rubio LA, Peng J, Rojas S, Rojas S, Crawford E, Black D, Jacobo J, Tulier-Laiwa V, Hoover CM, Martinez J, Jones D, Sachdev D, Cox C, Herrera E, Valencia R, Zurita KG, Chamie G, CLIAHUB Consortium, DeRisi J, Petersen M, Havlir DV, Marquez C. PMID: 33623805; PMCID: PMC7888566.

View in: PubMed Mentions: 13
Malignant Masses or Mysterious Mimic? Am J Med. 2021 03; 134(3):e217-e219. Brondfield S, Rubio L, Idossa D, Chin-Hong P. PMID: 33002492.

View in: PubMed Mentions: Fields:
Med Medicine (General)
Translation:Humans Cells
Clinical features, diagnostics, and outcomes of patients presenting with acute respiratory illness: A retrospective cohort study of patients with and without COVID-19. EClinicalMedicine. 2020 Oct; 27:100518. Shah SJ, Barish PN, Prasad PA, Kistler A, Neff N, Kamm J, Li LM, Chiu CY, Babik JM, Fang MC, Abe-Jones Y, Alipanah N, Alvarez FN, Botvinnik OB, Castaneda G, CZB CLIAhub Consortium, Dadasovich RM, Davis J, Deng X, DeRisi JL, Detweiler AM, Federman S, Haliburton J, Hao S, Kerkhoff AD, Kumar GR, Malcolm KB, Mann SA, Martinez S, Mary RK, Mick E, Mwakibete L, Najafi N, Peluso MJ, Phelps M, Pisco AO, Ratnasiri K, Rubio LA, Sellas A, Sherwood KD, Sheu J, Spottiswoode N, Tan M, Yu G, Kangelaris KN, Langelier C. PMID: 32864588; PMCID: PMC7447618.

View in: PubMed Mentions: 46
Coccidioidomycosis Presenting with Fever and Back Pain. J Gen Intern Med. 2020 06; 35(6):1887-1888. Pillsbury MM, Rubio LA, Lucas CG, Babik JM. PMID: 32185657; PMCID: PMC7280379.

View in: PubMed Mentions: 1 Fields:
Int Internal Medicine
Translation:Humans